SCHEMBL5767217

SCHEMBL5767217

COCCOc1ccc2c(c1)ncn2-c1ccc2cccc(-c3ccc(CN4CCC(NC(=O)OC(C)(C)C)CC4)cc3)c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.42
DRD4 P21917 4/20 0.41
GAK O14976 1/20 0.39
RIPK2 O43353 1/20 0.39
ULK1 O75385 1/20 0.39
STK10 O94804 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39
LATS1 O95835 1/20 0.39
PAK4 O96013 1/20 0.39
NTRK1 P04629 1/20 0.39
LCK P06239 1/20 0.39
CDK1 P06493 1/20 0.39
APRT P07741 1/20 0.39
RET P07949 1/20 0.39
PDGFRB P09619 1/20 0.39
PHKG2 P15735 1/20 0.39
NQO2 P16083 1/20 0.39
PDGFRA P16234 1/20 0.39
FECH P22830 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5765217 0.87 RET (0.40) GAKRIPK2ULK1STK10PRKD3
SCHEMBL5764531 0.86 RET (0.37) GAKRIPK2ULK1STK10PRKD3
SCHEMBL5766224 0.85 IRAK4 (0.51) AKT1GAKRIPK2ULK1STK10
SCHEMBL5763022 0.84 NTRK1 (0.42) GAKRIPK2ULK1STK10PRKD3
SCHEMBL5767426 0.83 IRAK4 (0.42) GAKRIPK2ULK1STK10PRKD3
SCHEMBL5766518 0.83 IRAK4 (0.42) GAKRIPK2ULK1STK10PRKD3
SCHEMBL5764066 0.83 IRAK4 (0.42) GAKRIPK2ULK1STK10PRKD3
SCHEMBL5765132 0.82 MAP3K11 (0.41) GAKRIPK2ULK1STK10PRKD3
SCHEMBL5765674 0.82 IRAK4 (0.40) GAKRIPK2ULK1STK10PRKD3
SCHEMBL5767092 0.82 IRAK4 (0.40) GAKRIPK2ULK1STK10PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019147-B1 Benzimidazole derivatives useful as antiproliferative agents PFIZER INC. (US) 2006-03-28 US claimed
EP-1235825-B1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS PFIZER PROD INC (US) 2006-01-25 EP claimed
EP-1235825-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS Pfizer Products Inc. (US) 2002-09-04 EP claimed
WO-2001040217-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS PFIZER PRODUCTS INC. (US) 2001-06-07 WO claimed
US-7019147-B1 Benzimidazole derivatives useful as antiproliferative agents PFIZER INC. (US) 2006-03-28 US disclosed
EP-1235825-B1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS PFIZER PROD INC (US) 2006-01-25 EP disclosed
EP-1235825-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS Pfizer Products Inc. (US) 2002-09-04 EP disclosed
WO-2001040217-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS PFIZER PRODUCTS INC. (US) 2001-06-07 WO disclosed